These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 13064837)

  • 21. New insights into complement: a mediator of injury and marker of disease activity in systemic lupus erythematosus.
    Manzi S; Ahearn JM; Salmon J
    Lupus; 2004; 13(5):298-303. PubMed ID: 15230282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Probable systemic lupus erythematosus with cell-bound complement activation products (CB-CAPS).
    Lamichhane D; Weinstein A
    Lupus; 2016 Aug; 25(9):1050-3. PubMed ID: 26911153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The expression of C3b receptors in the differentiation of discoid lupus erythematosus and systemic lupus erythematosus.
    Tausk F; Harpster E; Gigli I
    Arthritis Rheum; 1990 Jun; 33(6):888-92. PubMed ID: 2141982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum and cerebral spinal fluid complement and serum autoantibodies in systemic lupus erythematosus.
    Petz LD; Sharp GC; Cooper NR; Irvin WS
    Medicine (Baltimore); 1971 Jul; 50(4):259-75. PubMed ID: 4947126
    [No Abstract]   [Full Text] [Related]  

  • 25. Anticardiolipin antibody and complement.
    Cheng HM; Yap SF
    Arthritis Rheum; 1988 Sep; 31(9):1211-2. PubMed ID: 3422020
    [No Abstract]   [Full Text] [Related]  

  • 26. [Physical criteria of pathological processes. III. Structure of the correlation between the level of steady brain potential with serum complement proteins in rheumatic diseases].
    Klimenko LL; Kozlov LV; Kudriashova LP; Protasova OV; Maksimova IA; Komarova MN; Konradov AA; Turna AA; Soiustova EL; Matveev GN
    Biofizika; 1999; 44(1):128-31. PubMed ID: 10330589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Serum-complement factors in the pseudo-LE syndrome (author's transl)].
    Kaboth U; Niederhut H; Brunner G
    Dtsch Med Wochenschr; 1977 Apr; 102(13):470-3. PubMed ID: 844426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Erythrocyte complement receptor type 1 in patients with systemic lupus erythematosus.
    Yen JH; Liu HW; Lin SF; Chen JR; Chen TP
    J Rheumatol; 1989 Oct; 16(10):1320-5. PubMed ID: 2810256
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prolonged serologically active clinically quiescent systemic lupus erythematosus: frequency and outcome.
    Steiman AJ; Gladman DD; Ibañez D; Urowitz MB
    J Rheumatol; 2010 Sep; 37(9):1822-7. PubMed ID: 20595281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoantibodies against complement components in systemic lupus erythematosus - role in the pathogenesis and clinical manifestations.
    Hristova MH; Stoyanova VS
    Lupus; 2017 Dec; 26(14):1550-1555. PubMed ID: 29092674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. B cell and T cell lymphopenia in systemic lupus erythematosus.
    Scheinberg MA; Cathcart ES
    Cell Immunol; 1974 May; 12(2):309-14. PubMed ID: 4549192
    [No Abstract]   [Full Text] [Related]  

  • 32. Checking your patient's complement assay.
    Norris MK
    Nursing; 1994 Jan; 24(1):26. PubMed ID: 8278096
    [No Abstract]   [Full Text] [Related]  

  • 33. Update on complement in the pathogenesis of systemic lupus erythematosus.
    Molina H
    Curr Opin Rheumatol; 2002 Sep; 14(5):492-7. PubMed ID: 12192243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pathogenesis of complement decrease in the synovial fluid in rheumatoid arthritis and disseminated lupus erythematosus].
    Peltier AP; de Sèze S
    Rev Rhum Mal Osteoartic; 1971 Jan; 38(1):61-8. PubMed ID: 5549169
    [No Abstract]   [Full Text] [Related]  

  • 35. [Unusual complement deficiency in a patient with disseminated lupus erythematosus].
    Pondman KW; Hannema A; Cormane R; Stoop JW
    Ned Tijdschr Geneeskd; 1969 Aug; 113(34):1462-9. PubMed ID: 4896692
    [No Abstract]   [Full Text] [Related]  

  • 36. The effect of sera of patients with systemic lupus erythematosus on artificial immune complexes.
    Bányai A; Szabó G; Csongor J; Sonkoly I; Szegedi G
    Acta Med Hung; 1985; 42(1-2):51-7. PubMed ID: 4034337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complementary activity of the blood in rheumatism and certain allied disorders.
    KELLETT CE
    Ann Rheum Dis; 1954 Sep; 13(3):211-8. PubMed ID: 13198055
    [No Abstract]   [Full Text] [Related]  

  • 38. Complement in chronic cutaneous lupus erythematosus.
    Hunziker T; Mollnes TE; Misiano G; Späth PJ
    Br J Dermatol; 1988 Jan; 118(1):131-3. PubMed ID: 3257702
    [No Abstract]   [Full Text] [Related]  

  • 39. Lymphocyte tubuloreticular structures in lupus erythematosus. Correlation with disease activity.
    Ann Intern Med; 1974 Sep; 81(3):355-7. PubMed ID: 4368881
    [No Abstract]   [Full Text] [Related]  

  • 40. [Hematologic changes in the course of disseminated lupus erythematosus outside of the study of Hargraves' cell. Their contribution to the diagnosis and concept of lupus].
    DEBRAY J
    Sem Hop; 1962 Jan; 38():46-55. PubMed ID: 13884692
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.